Kathy H. Gaddes Sells 2,652 Shares of AmerisourceBergen Corp. (ABC) Stock
AmerisourceBergen Corp. (NYSE:ABC) insider Kathy H. Gaddes sold 2,652 shares of AmerisourceBergen stock in a transaction that occurred on Tuesday, November 20th. The shares were sold at an average price of $90.54, for a total value of $240,112.08. Following the transaction, the insider now owns 4,591 shares of the company’s stock, valued at $415,669.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
ABC stock traded down $1.44 during trading on Wednesday, hitting $87.43. 1,252,900 shares of the company traded hands, compared to its average volume of 1,578,275. The company has a current ratio of 0.93, a quick ratio of 0.50 and a debt-to-equity ratio of 1.36. The stock has a market cap of $19.65 billion, a P/E ratio of 13.47, a P/E/G ratio of 1.35 and a beta of 0.97. AmerisourceBergen Corp. has a 1 year low of $77.28 and a 1 year high of $106.27.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Tuesday, November 6th. The company reported $1.45 EPS for the quarter, beating the Zacks’ consensus estimate of $1.44 by $0.01. The business had revenue of $43.30 billion during the quarter, compared to analysts’ expectations of $43.27 billion. AmerisourceBergen had a return on equity of 45.54% and a net margin of 0.99%. The business’s revenue was up 10.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.33 earnings per share. On average, research analysts predict that AmerisourceBergen Corp. will post 6.81 earnings per share for the current fiscal year.
ABC has been the subject of several recent research reports. Zacks Investment Research cut AmerisourceBergen from a “hold” rating to a “sell” rating in a research report on Wednesday, October 3rd. Mizuho reiterated a “neutral” rating on shares of AmerisourceBergen in a research report on Wednesday, September 19th. ValuEngine upgraded AmerisourceBergen from a “sell” rating to a “hold” rating in a research report on Wednesday, September 19th. Robert W. Baird reiterated a “hold” rating and set a $89.00 price target on shares of AmerisourceBergen in a research report on Friday, August 3rd. Finally, Royal Bank of Canada set a $90.00 price target on AmerisourceBergen and gave the company a “hold” rating in a research report on Wednesday, November 7th. Eight research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $101.07.
Institutional investors have recently bought and sold shares of the company. Migdal Insurance & Financial Holdings Ltd. increased its position in shares of AmerisourceBergen by 140.9% in the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,142 shares of the company’s stock valued at $105,000 after buying an additional 668 shares in the last quarter. First Mercantile Trust Co. purchased a new stake in shares of AmerisourceBergen in the second quarter valued at approximately $107,000. Financial Gravity Wealth Inc. increased its position in shares of AmerisourceBergen by 93.2% in the third quarter. Financial Gravity Wealth Inc. now owns 1,254 shares of the company’s stock valued at $108,000 after buying an additional 605 shares in the last quarter. Truvestments Capital LLC purchased a new stake in shares of AmerisourceBergen in the third quarter valued at approximately $120,000. Finally, Centaurus Financial Inc. purchased a new stake in shares of AmerisourceBergen in the second quarter valued at approximately $129,000. Institutional investors and hedge funds own 64.73% of the company’s stock.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Featured Article: Compound Interest
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.